This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

IceCure Medical Future Growth

Future criteria checks 2/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for IceCure Medical.

Key information

32.8%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth20.5%
Revenue growth rate47.5%
Future return on equityn/a
Analyst coverage

Low

Last updated24 Jul 2023

Recent future growth updates

No updates

Recent updates

Will IceCure Medical (TLV:ICCM) Spend Its Cash Wisely?

Jul 13
Will IceCure Medical (TLV:ICCM) Spend Its Cash Wisely?

Here's Why We're Watching IceCure Medical's (TLV:ICCM) Cash Burn Situation

Mar 29
Here's Why We're Watching IceCure Medical's (TLV:ICCM) Cash Burn Situation

Are Investors Undervaluing IceCure Medical Ltd (TLV:ICCM) By 29%?

Sep 06
Are Investors Undervaluing IceCure Medical Ltd (TLV:ICCM) By 29%?

Is IceCure Medical Ltd (TLV:ICCM) Potentially Undervalued?

Mar 03
Is IceCure Medical Ltd (TLV:ICCM) Potentially Undervalued?

Is IceCure Medical (TLV:ICCM) In A Good Position To Deliver On Growth Plans?

Dec 13
Is IceCure Medical (TLV:ICCM) In A Good Position To Deliver On Growth Plans?

Earnings and Revenue Growth Forecasts

TASE:ICCM - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202536-1-13N/A2
12/31/202411-14-21N/A4
12/31/20235-16-17-154
3/31/20233-16-15-14N/A
12/31/20223-17-15-14N/A
9/30/20224-16-17-16N/A
6/30/20224-15-17-16N/A
3/31/20223-13-14-14N/A
12/31/20214-10-13-13N/A
9/30/20214-8-9-8N/A
6/30/20214-6-7-6N/A
3/31/20214-4-5-5N/A
12/31/20204-4-4-4N/A
9/30/20203-4-2-2N/A
6/30/20203-4-10N/A
3/31/20202-4-1-1N/A
12/31/20192-5-2-2N/A
9/30/20191-5N/AN/AN/A
6/30/20191-4-4-4N/A
3/31/20191-4-4-4N/A
12/31/20181-4-3-3N/A
9/30/20181-3N/AN/AN/A
6/30/20181-3-3-3N/A
3/31/20181-3-3-3N/A
12/31/20171-3-3-3N/A
9/30/20171-3-3-3N/A
6/30/20171-3-3-3N/A
3/31/20171-3-3-3N/A
12/31/20161-3N/A-3N/A
9/30/20161-3N/A-3N/A
6/30/20161-4N/A-4N/A
3/31/20161-4N/A-3N/A
12/31/20151-4N/A-3N/A
9/30/20151-4N/A-3N/A
6/30/20151-4N/A-3N/A
3/31/20151-4N/A-3N/A
12/31/20141-5N/A-3N/A
9/30/20141-5N/A-4N/A
6/30/20141-5N/A-4N/A
3/31/20140-5N/A-3N/A
12/31/20130-5N/A-3N/A
9/30/20130-5N/A-4N/A
6/30/20130-5N/A-4N/A
3/31/20130-5N/A-4N/A
12/31/20120-5N/A-4N/A
9/30/20120-4N/A-4N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ICCM is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ICCM is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ICCM is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ICCM's revenue (47.5% per year) is forecast to grow faster than the IL market (4.5% per year).

High Growth Revenue: ICCM's revenue (47.5% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ICCM's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.